TITLE

PASS NOTES: HRT--Part 2

AUTHOR(S)
Newson, Louise
PUB. DATE
September 2003
SOURCE
GP: General Practitioner;9/29/2003, p46
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Observational studies have reported that the risk of ischaemic heart disease may be reduced by up to 40 per cent in women taking hormone replacement therapy. However, there are differences between studies thought to be related to selection bias, so interpretation is extremely difficult. The Heart and Estrogen/Progestin Replacement study was the first randomised controlled trial of 2,763 postmenopausal American women with ischaemic heart disease. Data showed combined oestrogen and progestogen had no effect on myocardial infarction or coronary death after treatment for 4.1 years. One study looked at angiographic progression of existing coronary artery disease and found no effect of either oestrogen or combined oestrogen and progestogen over a three-year period. INSET: Summary points.
ACCESSION #
11121217

 

Related Articles

  • Postmenopausal Hormone Use in Women with Acute Coronary Syndromes. Parsons, Elizabeth; Newby, L. Kristin; Bhapkar, Manjushri V.; Alexander, Karen P.; White, Harvey D.; Shah, Svati H.; Bushnell, Cheryl D.; Califf, Robert M. // Journal of Women's Health (15409996);Oct2004, Vol. 13 Issue 8, p863 

    Background: Recent trials reveal no benefit and possible harm from chronic hormone replacement therapy (HRT). Less is known about intermediate-term outcomes associated with HRT use in the setting of acute coronary syndromes (ACS). Methods: To examine the prevalence of HRT use and relationships...

  • Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study. Grodstein, Francine; Manon, JoAnn E.; Stampfer, Meir J. // Annals of Internal Medicine;7/3/2001, Vol. 135 Issue 1, p1 

    Discusses results of a study on the effectiveness of postmenopausal hormone use in the secondary prevention of coronary events. Patient characteristics; Decreasing recurrence of major coronary heart disease events with increasing duration of hormone use; Absence of difference between users of...

  • HRT does not prevent heart disease. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);8/16/2003, Vol. 327 Issue 7411, p359 

    Discusses how hormone replacement therapy (HRT) does not prevent coronary heart disease. Consideration of a medical trial that compared the combined estrogen and progestogen treatment with placebo; Risk of myocardial infarction and death in women who were given a placebo; Role of oestrogen in...

  • POSTMENOPAUSAL HORMONE THERAPY AND CARDIOVASCULAR RISK. VandeKieft, Gregg // Journal of Family Practice;Nov1996, Vol. 43 Issue 5, p437 

    This article discusses research being done on the link between combination hormone replacement therapy (HRT) and the risk of cardiovascular disease. It references a study published in a 1996 issue of the "New England Journal of Medicine." Combined progestin and estrogen therapy has become the...

  • Hormone use and cardiovascular impact--age matters.  // Patient Care;Mar2006, Vol. 40 Issue 3, p9 

    Presents the results of studies on the link of postmenopausal hormone therapy (HT) to coronary heart disease. Benefits of early start of HT therapy on women who are near their menopausal period; Outcome of a Women's Health Initiative Study of combined estrogen and progestin therapy among...

  • MEDICINE IN THE NEWS. Kaplan, Deborah // Patient Care for the Nurse Practitioner;Mar2006, Vol. 9 Issue 3, p9 

    The article reports on a study which examined postmenopausal hormone therapy and the timing of its use. Discrepant findings between the Women's Health Initiative compared with observational studies of postmenopausal HT and coronary heart disease (CHD) led researchers to conduct the study. They...

  • Oestrogen plus progestin reduced risk of fracture in postmenopausal women. Cauley, J. A.; Robbins, J.; Chen, Z. // Evidence Based Medicine;May/Jun2004, Vol. 9 Issue 3, p82 

    The article discusses effects of oestrogen plus progestin in reducing the risk of fracture in postmenopausal women. Women above 50 and an intact uterus in the hormone therapy group than in the placebo group had a fracture. The effect of total fracture risk remained constant across different...

  • Do the risks of estrogen plus progestin outweigh the benefits in healthy postmenopausal women? Lindbloom, Erik J. // Journal of Family Practice;Oct2002, Vol. 51 Issue 10, p821 

    The article discusses research on the risks and benefits of postmenopausal hormone replacement therapy (HRT) in health postmenopausal women. It references a study published in a 2002 issue of the "Journal of the American Medical Association." This trial assessed the HRT regimen using estrogen...

  • What do we tell our patients now about HRT? Lockwood, Charles J. // Contemporary OB/GYN;Aug2002, Vol. 47 Issue 8, p8 

    Discusses the findings of several studies concerning the risks associated with hormone replacement therapy (HRT). Medical conditions associated with the use of estrogen and progestin therapy; Overview of studies contradicting the association between HRT and coronary heart disease; Notions about...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics